Enveric Biosciences Inc ENVB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:15 AM EDT
1.00quote price arrow down-0.02 (-1.96%)
Volume
10,764
Close
1.02quote price arrow down-0.04 (-3.77%)
Volume
373,756
52 week range
0.65 - 6.98
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.02
  • 52 Week High6.98
  • 52 Week High Date05/24/23
  • 52 Week Low0.65
  • 52 Week Low Date02/01/24

Key Stats

  • Market Cap7.44M
  • Shares Out7.29M
  • 10 Day Average Volume5.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change-21.54

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.02
  • 52 Week High6.98
  • 52 Week High Date05/24/23
  • 52 Week Low0.65
  • 52 Week Low Date02/01/24
  • Market Cap7.44M
  • Shares Out7.29M
  • 10 Day Average Volume5.72M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change-21.54

RATIOS/PROFITABILITY

  • EPS (TTM)-8.15
  • P/E (TTM)-0.13
  • Fwd P/E (NTM)-0.24
  • EBITDA (TTM)-16.104M
  • ROE (TTM)-209.99%
  • Revenue (TTM)-
  • Gross Margin (TTM)22.25%
  • Net Margin (TTM)-19.34%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Enveric Biosciences Inc

 

Profile

MORE
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. The Company through Psybrary has created a robust intellectual property (IP) portfolio of New Chemical Entities (NCEs) for specific mental health indications or physical ailments. The Company's lead program, EB-373, is a next-generation prodrug of psilocin, the active metabolite...
Mike Webb
Non-Executive Independent Chairman of the Board
Joseph Tucker Ph.D.
Chief Executive Officer, Director
Kevin Coveney
Chief Financial Officer
Address
4851 Tamiami Trail N, Suite 200
Naples, FL
34103
United States

Top Peers

SYMBOLLASTCHG%CHG
HOTH
Hoth Therapeutics Inc
1.38-0.11-7.38%
TENX
Tenax Therapeutics Inc
3.87+0.16+4.31%
PCSA
Processa Pharmaceuticals Inc
2.27+0.10+4.61%
ATXI
Avenue Therapeutics Inc
0.1526+0.0016+1.0596%
CING
Cingulate Inc
1.09-0.02-1.80%